Elevated PRL levels during MS and NMO attacks, particularly the more pronounced elevations observed during myelitis episodes, suggest a potential immunomodulatory role for PRL in the pathogenesis of autoimmune demyelinating diseases [113] (Table 3). The gene discussed is PRL; the disease is myeloid sarcoma.